Arix Bioscience PLC (ARIX)
Result of Annual General Meeting
23-May-2023 / 16:30 GMT/BST
Arix Bioscience plc Result of Annual General Meeting LONDON, 23 May 2023: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a transatlantic venture capital company focused on investing in breakthrough biotechnology companies, announces that at its Annual General Meeting (the "Meeting") duly convened and held today, all resolutions as set out on the notice of meeting were duly passed by way of a poll. Resolutions 1 to 11 were passed as ordinary resolutions. Resolutions 12 to 15 were passed as special resolutions. Full details of the poll results are set out below and will also be available on the Company's . No | RESOLUTION | VOTES FOR | % | VOTES AGAINST | % | TOTAL VOTES | % of ISC VOTED | VOTES WITHHELD | 1 | To receive the Directors' Report and the accounts of the Company for the year ended 31 December 2022 | 68,931,411 | 100.00% | 3,441 | 0.00% | 68,934,852 | 53.28% | 8,440 | 2 | To approve the Directors' Remuneration Report | 61,073,950 | 89.25% | 7,358,207 | 10.75% | 68,432,157 | 52.89% | 511,135 | 3 | To re-elect Peregrine Moncreiffe as a Director | 68,099,019 | 98.79% | 834,821 | 1.21% | 68,933,840 | 53.28% | 9,452 | 4 | To re-elect Maureen O'Connell as a Director | 68,894,053 | 99.94% | 42,077 | 0.06% | 68,936,130 | 53.28% | 7,162 | 5 | To re-elect Isaac Kohlberg as a Director | 68,900,656 | 99.98% | 17,184 | 0.02% | 68,917,840 | 53.26% | 25,452 | 6 | To re-elect Robert Lyne as a Director | 68,902,689 | 99.95% | 31,595 | 0.05% | 68,934,284 | 53.28% | 9,008 | 7 | To elect Dr. Debra Barker as a Director | 68,907,528 | 99.95% | 32,248 | 0.05% | 68,939,776 | 53.28% | 3,516 | 8 | To elect Andrew Smith as a Director | 68,921,195 | 99.98% | 13,089 | 0.02% | 68,934,284 | 53.28% | 9,008 | 9 | To appoint BDO LLP as auditors of the Company | 68,929,881 | 99.99% | 7,445 | 0.01% | 68,937,326 | 53.28% | 5,966 | 10 | To authorise the Audit and Risk Committee of the Company to fix the auditor's remuneration | 68,934,245 | 100.00% | 2,013 | 0.00% | 68,936,258 | 53.28% | 7,034 | 11 | To authorise the Directors to allot shares | 65,989,256 | 95.72% | 2,950,520 | 4.28% | 68,939,776 | 53.28% | 3,516 | 12 | Authority to disapply statutory pre‐ emption rights | 62,199,252 | 90.23% | 6,734.680 | 9.77% | 68,933,932 | 53.28% | 9,360 | 13 | Additional authority to disapply statutory pre‐ emption rights | 62,202,105 | 90.23% | 6,731,827 | 9.77% | 68,933,932 | 53.28% |
|
